Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
We summarize typical holdings and how index funds achieve broad market exposure with a defined set of constituents.
15,010 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
A narrow semiconductor ETF has surged as AI demand drives capex in data centers. This semiconductor only need to prov...
A little-known Fidelity fund is posting strong returns as demand for electrification and data-center power infrastruc...
A niche ETF that targets closed-end funds is delivering roughly 15% total return over the past year, while its holdin...
A major fund recently added a sizable Mosaic position, highlighting growing interest in fertilizer stocks as potash p...
As markets shift in 2026, dividend-focused funds regain attention. This guide breaks down the ishares core high divid...
Eli Lilly has faced a pullback that can create long-term buying opportunities. This guide explores using a budget-fri...
Schwab’s dividend ETF SCHD rolled out a major reconstitution, removing 22 stocks and adding several higher-growth div...
The Nasdaq leads the charge as risk appetite returns, lifting major indices. This guide breaks down what’s driving th...
A prominent hedge fund reduced its Wix stake by 25,000 shares in late 2025. This article breaks down what dorsal capi...
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
IVV and SPY both track the S&P 500, but they aren’t identical. This guide breaks down cost, liquidity, tax considerat...